FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pulmonology, and can be used in laboratory diagnosis of pneumonia. The laboratory diagnostic technique in pneumonia consists in measuring blood serum surfactant protein A and/or surfactant protein D by enzyme immunoassay (EIA); if the measured surfactant protein A level is more than 49.56 ng/ml, or the measured surfactant protein D level is more than 234.39 ng/ml, pneumonia is diagnosed.
EFFECT: technique is non-invasive and enables diagnosing pneumonia in due time.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING SEVERITY OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2021 |
|
RU2767892C1 |
| METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2789426C1 |
| METHOD OF DIAGNOSING VOLUME OF LUNG TISSUE AFFECTION IN CASE OF OUT-OF-HOSPITAL PNEUMONIA IN ADULTS BY DETERMINATION OF SERUM ALVEOMUCIN LEVEL | 2009 |
|
RU2407014C1 |
| METHOD FOR FAT EMBOLISM SYNDROME DIAGNOSIS IN CASE OF LOWER LIMB BONE FRACTURES | 2016 |
|
RU2611363C1 |
| METHOD FOR PREDICTING THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795093C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PNEUMONIA AND INFILTRATIVE PULMONARY TUBERCULOSIS | 2011 |
|
RU2444015C1 |
| METHOD OF EARLY DIAGNOSTICS OF VIRAL PNEUMONIA | 2010 |
|
RU2440577C1 |
| METHOD FOR DETERMINING CLINICAL COURSE OF CHRONIC OCCUPATIONAL BRONCHITIS | 2020 |
|
RU2733866C1 |
| DIAGNOSTIC TECHNIQUE OF ACUTE BRONCHOPULMONARY DISEASES IN CHILDREN | 2011 |
|
RU2459206C2 |
| METHOD FOR DETERMINING COMMUNITY-ACQUIRED PNEUMONIA CLINICAL COURSE SEVERITY DEGREE | 2005 |
|
RU2302637C1 |
